# ClinicalTrials.gov record NCT02387359

> PeptideScanner retained ClinicalTrials.gov record NCT02387359 at 2026-07-30T20:50:35.893Z. Its registry update date was 2019-06-14, and PeptideScanner's reviewed identity mapping was plecanatide.

- Evidence object: `story:clinicaltrials-gov-nct02387359-plecanatide:v1`
- Evidence domain: Clinical trials
- Date in source: 2019-06-14
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct02387359-plecanatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct02387359-plecanatide-v1.json
- Content SHA-256: `97405ac6cf7c2fc0b0f7af33cba23fc23cd65d6e119c58f6741940c1fa62eb8c`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT02387359 ([`ctg-observation-nct02387359-2019-06-14-16831baece36`](#source-ctg-observation-nct02387359-2019-06-14-16831baece36))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT02387359 at 2026-07-30T20:50:35.893Z. Its registry update date was 2019-06-14, and PeptideScanner's reviewed identity mapping was plecanatide. ([`ctg-observation-nct02387359-2019-06-14-16831baece36`](#source-ctg-observation-nct02387359-2019-06-14-16831baece36))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT02387359 at 2026-07-30T20:50:35.893Z. Its registry update date was 2019-06-14, and PeptideScanner's reviewed identity mapping was plecanatide. ([`ctg-observation-nct02387359-2019-06-14-16831baece36`](#source-ctg-observation-nct02387359-2019-06-14-16831baece36))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct02387359-2019-06-14-16831baece36`](#source-ctg-observation-nct02387359-2019-06-14-16831baece36))

## Sources

<a id="source-ctg-observation-nct02387359-2019-06-14-16831baece36"></a>
- **ClinicalTrials.gov record NCT02387359 · retained source version 2019-06-14:16831baece36019a5844daa8ab5963573216134c8cbc1d3930fd07268b2234c4** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT02387359) (`ctg-observation-nct02387359-2019-06-14-16831baece36`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT02387359." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct02387359-plecanatide-v1.json SHA-256: 97405ac6cf7c2fc0b0f7af33cba23fc23cd65d6e119c58f6741940c1fa62eb8c.